Developing a sensitive tool to detect individual biological targets.
A Bipolar Electrochemical Single Entity Bioanalyzer
This study is working on a new, super-sensitive tool that can find tiny amounts of important markers in your blood that could help doctors spot diseases like cancer earlier and more accurately.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10904859 on NIH RePORTER |
What this research studies
This research focuses on creating a highly sensitive electrochemical platform that can detect and quantify individual biological species, such as cancer biomarkers, which are often present in very low concentrations. By utilizing advanced optical microscopy and bipolar microelectrode arrays, the project aims to improve the detection capabilities beyond current methods. Patients may benefit from this technology as it could lead to earlier and more accurate diagnoses of diseases by identifying specific biological markers in their blood or other samples.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that produce low-concentration biomarkers, such as certain cancers.
Not a fit: Patients with conditions that do not involve detectable biomarkers or those whose biomarkers are present in sufficient quantities for existing detection methods may not benefit.
Why it matters
Potential benefit: If successful, this research could enable earlier detection of diseases through improved identification of critical biomarkers.
How similar studies have performed: Similar approaches in developing sensitive detection technologies have shown promise in other biomedical research, indicating potential for success in this novel application.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Zhang, Bo — University of Washington
- Study coordinator: Zhang, Bo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.